US Stock MarketDetailed Quotes

ANEB Anebulo Pharmaceuticals

Watchlist
  • 2.704
  • -0.091-3.25%
Close Apr 26 16:00 ET
70.11MMarket Cap-6594P/E (TTM)

Anebulo Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Anebulo Pharmaceuticals Earnings Date

Currency: USD

Period

Q2 FY2024 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.11

+26.67%
Analyst Rating

Buy

Mar 31, 2024

Anebulo Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 0.000--
--2024/Q3-- / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--

Unlock Free Earnings Estimates

Anebulo Pharmaceuticals Earnings Reports

  • Anebulo Pharmaceuticals | 10-Q: Quarterly report

    Feb 13 16:38 ET

  • Anebulo Pharmaceuticals: Q1 2024 Earnings Report

    Nov 14, 2023 16:30 ET

  • Anebulo Pharmaceuticals | 10-K: FY2023 Annual Report

    Sep 22, 2023 16:05 ET

  • Anebulo Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    May 11, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Mar 31, 2024

    Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg